According to lately carried out experiments, cannabis will be thought-about as an efficient treatment for sufferers diagnosed with multiple sclerosis. While at first the symptomatic improvements experienced by sufferers with multiple sclerosis who’ve been administered cannabinoid products had been considered determined solely by psychological elements, later analysis has revealed that cannabis truly reduces muscular spasms and stiffness attributed to multiple sclerosis sufferers. The benefic effects of cannabis on sufferers with the disease like MS have been confirmed by short-term and long-term controlled medical studies.
In 2003, a group of researchers from the Peninsula Medical School in Exeter, UK have made public the results of a series of short-term and long-term studies on the effects of cannabinoids amongst sufferers with multiple sclerosis. The beforehand carried out studies involved the active participation of around 600 sufferers with advanced-stage multiple sclerosis. The participants had been divided in two distinctive teams: the first group received cannabinoid compounds in equal doses, while the second group received placebo drugs over a period of 15 weeks. By the end of the experiment, the vast majority of sufferers who had been administered cannabinoids experienced appreciable symptomatic improvements, having less muscular pain and being confronted with milder muscular spasticity (less pronounced muscular spasm). Not like the group that received cannabinoid compounds over the whole period of the study, the control group (sufferers who received placebo drugs) experienced no improvements of their general condition.
With a view to verify the relevancy of the findings and to discard any doubts in regards to the effectivity of cannabis in ameliorating the signs of multiple sclerosis, the study was later repeated. The ulterior study was performed over a period of 12 months, and involved the participation of the same subjects. However, this time the participants were divided into 3 distinctive teams as a substitute of 2 as in the case of the earlier experiment. The first group received drugs of D9-tetrahydrocannabinol (THC) – the active element in cannabis, the second group received natural cannabis extracts, while the third group received placebo medications.
At the end of the experiment, sufferers had been carefully evaluated and examined by a group of physiotherapists and neurologists. The perfect results had been obtained among the many sufferers belonging to the first study group, the vast majority of subjects who’ve received equal doses of THC experiencing considerable improvements of their symptoms. The sufferers in the second study group experienced slight improvements in their signs, while the sufferers in the third group felt no changes in their condition.
Regardless of the actual fact these studies clearly suggest that cannabis is an efficient treatment for multiple sclerosis, medical scientists aren’t still convinced that cannabinoids will be successfully used in the therapy of multiple sclerosis. However, after performing additional studies on the matter and more elaborate analysis, medical doctors could consider to introduce cannabinoid compounds in the treatment of multiple sclerosis in the near future.
No related posts.
